Yale: Seven-Day Buprenorphine is Safe for Those With Minimal Opioid Withdrawal
July 09, 2024
July 09, 2024
NEW HAVEN, Connecticut, July 9 (TNSres) -- Yale University issued the following news:
By Mallory Locklear
A seven-day, extended-release version of buprenorphine -- a treatment for opioid use disorder (OUD) that can reduce opioid use and overdose deaths -- is safe and effective for people with OUD experiencing minimal symptoms of withdrawal, a new Yale study finds.
Individuals with minimal opioid withdrawal are often not prescribed the more common under-the- . . .
By Mallory Locklear
A seven-day, extended-release version of buprenorphine -- a treatment for opioid use disorder (OUD) that can reduce opioid use and overdose deaths -- is safe and effective for people with OUD experiencing minimal symptoms of withdrawal, a new Yale study finds.
Individuals with minimal opioid withdrawal are often not prescribed the more common under-the- . . .